AperçuGraphiqueActualitésTraderScreen

Soc. Generale Knock-Out BMY/  DE000SW522Z3  /

Frankfurt Zert./SG
15/11/2024  21:47:23 Chg.-0.230 Bid21:59:27 Demandez à21:59:27 Sous-jacent Prix d'exercice Date d'expiration Type d'option
2.770EUR -7.67% 2.780
Bid taille: 5,000		 2.790
Ask la taille: 5,000		 Bristol Myers Squibb... 26.8899 USD 31/12/2078 Call
TeleTrader 11/11 US closes mostly higher ahead of inflation data
TeleTrader 11/11 Dow gains 330 points at open after record week
GlobeNewswire 03/09 Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer
GlobeNewswire 02/09 CSE Announces its 2024 Sustainability & ESG Leadership Summit at NYC's One World Trade Center
GlobeNewswire 30/08 Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire 29/08 Immunocore announces transition of Chief Financial Officer
GlobeNewswire 28/08 Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising A...
GlobeNewswire 22/08 Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive ...
GlobeNewswire 15/08 Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire 12/08 Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in C...
Newsfile Corp 12/08 The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
GlobeNewswire 12/08 Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
GlobeNewswire 08/08 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 07/08 Efficacy and Safety Data of Sotagliflozin in Patients with Type 1 Diabetes and Chronic Kidney Diseas...
GlobeNewswire 06/08 ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors
GlobeNewswire 05/08 iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer
GlobeNewswire 01/08 Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire 01/08 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire 31/07 Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Boar...
GlobeNewswire 30/07 Anaveon appoints Dieter Weinand as Chair of its Board of Directors
GlobeNewswire 25/07 Purple Biotech Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price Rule
GlobeNewswire 24/07 Prota Therapeutics Strengthens Board with Appointment of Global Biotech Expert Patrick Machado
GlobeNewswire 20/07 NCLA Asks Third Circuit to Rule Against HHS’s Coercive Medicare Drug Price ‘Negotiation’ Program
GlobeNewswire 17/07 Nouscom Appoints Tiffany Muller as Chief Financial Officer and Loredana Siani as Senior Vice Preside...
GlobeNewswire 09/07 VYNE Therapeutics Announces Appointment of Subhashis Banerjee, M.D. as Senior Vice President of Clin...